Cargando…

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy

As cancer strikes, individuals vary not only in terms of factors that contribute to its occurrence and development, but as importantly, in their capacity to respond to treatment. While exciting new therapeutic options that mobilize the immune system against cancer have led to breakthroughs for a var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gnjatic, Sacha, Bronte, Vincenzo, Brunet, Laura Rosa, Butler, Marcus O., Disis, Mary L., Galon, Jérôme, Hakansson, Leif G., Hanks, Brent A., Karanikas, Vaios, Khleif, Samir N., Kirkwood, John M., Miller, Lance D., Schendel, Dolores J., Tanneau, Isabelle, Wigginton, Jon M., Butterfield, Lisa H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432988/ https://www.ncbi.nlm.nih.gov/pubmed/28515944 http://dx.doi.org/10.1186/s40425-017-0243-4

Ejemplares similares

Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force
por: Butterfield, Lisa H, et al.
Publicado: (2010)

Preamble to the 2015 SITC immunotherapy biomarkers taskforce
por: Butterfield, Lisa H, et al.
Publicado: (2015)

Immunotherapy biomarkers 2016: overcoming the barriers
por: Gulley, James L., et al.
Publicado: (2017)

SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
por: Butterfield, Lisa H., et al.
Publicado: (2018)

Toward integrative cancer immunotherapy: targeting the tumor microenvironment
por: Emens, Leisha A, et al.
Publicado: (2012)

A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"
por: Butterfield, Lisa H, et al.
Publicado: (2008)

Focus on the target: the tumor microenvironment, Society for Immunotherapy of Cancer Annual Meeting Workshop, October 24th-25th 2012
por: Sunay, Melek Erdinc, et al.
Publicado: (2013)

Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule
por: Kaufman, Howard L., et al.
Publicado: (2016)

Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I—conceptual challenges
por: Rutella, Sergio, et al.
Publicado: (2020)

Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume II—practical challenges
por: Cesano, Alessandra, et al.
Publicado: (2020)

The Great Debate at ‘Immunotherapy Bridge’, Naples, December 5, 2019
por: Ascierto, Paolo A, et al.
Publicado: (2020)

Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapy
por: Tsuji, Takemasa, et al.
Publicado: (2012)

Strategies and designs for combination immune therapy
por: Khleif, Samir
Publicado: (2015)

Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma
por: Tarhini, Ahmad A., et al.
Publicado: (2015)

Evolution by innovation as a driving force to improve TCR-T therapies
por: Schendel, Dolores J.
Publicado: (2023)

Intratumoral checkpoint subversion as a strategy for minimizing adverse effects: Harvesting the power of TILs without harvesting TILs
por: Alabanza, Leah, et al.
Publicado: (2014)

Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity
por: Germain, Claire, et al.
Publicado: (2015)

High-quality and high-avidity T cell clones specific for tumor-associated antigens and how to find them
por: Wilde, Susanne, et al.
Publicado: (2012)

Limitations for TCR gene therapy by MHC-restricted fratricide and TCR-mediated hematopoietic stem cell toxicity
por: Schendel, Dolores J., et al.
Publicado: (2013)

GENETIC CONTROL OF CELL-MEDIATED LYMPHOLYSIS IN MOUSE
por: Schendel, Dolores J., et al.
Publicado: (1974)

CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-ζ chain expression
por: Schüle, Jana M, et al.
Publicado: (2004)

510. Elevated IL-1β level as a predictor of inflammation and death in COVID-19
por: Swartz, Talia H, et al.
Publicado: (2020)

Multiplex serum biomarker assessments: technical and biostatistical issues
por: Butterfield, Lisa H, et al.
Publicado: (2011)

NOD/scid IL-2Rg(null )mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo
por: Spranger, Stefani, et al.
Publicado: (2012)

AKT inhibition mitigates terminal differentiation and preserves central memory phenotype of CD8 T cells
por: Abu Eid, Rasha, et al.
Publicado: (2014)

Effect of once weekly dulaglutide by baseline beta‐cell function in people with type 2 diabetes in the AWARD programme
por: Mathieu, Chantal, et al.
Publicado: (2018)

Understanding the drug exposure–response relationship of bedaquiline to predict efficacy for novel dosing regimens in the treatment of multidrug‐resistant tuberculosis
por: Tanneau, Lénaïg, et al.
Publicado: (2020)

Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics
por: Esai Selvan, Myvizhi, et al.
Publicado: (2023)

Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy
por: Iovino, Lorenzo, et al.
Publicado: (2021)

Effects of baseline symptom burden on treatment response in COPD
por: Martinez, Fernando J, et al.
Publicado: (2019)

Reductions in inhaler greenhouse gas emissions by addressing care gaps in asthma and chronic obstructive pulmonary disease: an analysis
por: Gagné, Myriam, et al.
Publicado: (2023)

Role of the Wnt-β-catenin signaling pathway in melanoma-mediated dendritic cell tolerization
por: Holtzhausen, Alisha, et al.
Publicado: (2013)

Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report
por: Mohammed, Altaf, et al.
Publicado: (2021)

Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
por: Wong, Serre-Yu, et al.
Publicado: (2021)

Exposure–safety analysis of QTc interval and transaminase levels following bedaquiline administration in patients with drug‐resistant tuberculosis
por: Tanneau, Lénaïg, et al.
Publicado: (2021)

Biodiversity baseline of the French Guiana spider fauna
por: Vedel, Vincent, et al.
Publicado: (2013)

CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data
por: Bindea, Gabriela, et al.
Publicado: (2013)

Usefulness and robustness of Immunoscore for personalized management of cancer patients
por: Marliot, Florence, et al.
Publicado: (2020)

Automated exploration of gene ontology term and pathway networks with ClueGO-REST
por: Mlecnik, Bernhard, et al.
Publicado: (2019)

Expand to shield: IL-15 and in situ lymphocytic proliferation
por: Bindea, Gabriela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mts1vs0e7svdvvbjcm7rjv7o9s